Clinical communication to the EditorMonotherapy with Ezetimibe Causing Myopathy
References (4)
- et al.
Statin myotoxicity is associated with changes in cardiopulmonary function
Atherosclerosis
(2004) Merck/Schering-Plough package insert. Physicians’ Desk Reference, 2005.
(2005)
Cited by (37)
Is it really myositis? Mimics and pitfalls
2022, Best Practice and Research: Clinical RheumatologyStatin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia
2016, American Heart JournalCitation Excerpt :In one case report, a patient with a history of a history of statin-associated exercise-induced muscle pain developed muscle symptoms again when treated alone with ezetimibe. Her symptoms promptly resolved after stopping ezetimibe.19 Similarly, in another report, a patient with dyslipidemia, a strong family history of CHD, Raynaud's phenomenon, and statin-associated muscle symptoms who was symptom-free after stopping statin developed muscle symptoms again after only 2 weeks of ezetimibe therapy.20
Iatrogenic neurology
2014, Handbook of Clinical NeurologyDrugs Causing Muscle Disease
2011, Rheumatic Disease Clinics of North AmericaCitation Excerpt :The most prevalent drug-induced myopathies are those caused by lipid-lowering agents. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), fibric acid derivatives (fibrates), niacin, and ezetimibe may all cause myopathy in some patients.1,2 However, it should be noted that the high prevalence of myotoxicities associated with these agents is not because of a large risk from their use but rather because the use of such drugs is extremely common.3
Drugs that affect lipid metabolism
2010, Side Effects of Drugs AnnualNeurotoxic Effects of Pharmaceutical Agents V: Miscellaneous Agents
2009, Clinical Neurotoxicology: Syndromes, Substances, Environments, Expert Consult - Online and Print